Total Valuation
MedCap AB has a market cap or net worth of €752.94M. The enterprise value is €8.03K.
Market Cap€752.94M
Enterprise Value€8.03K
Share Statistics
MedCap AB has 15,080,753 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding15,080,753
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
MedCap AB’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 10.35%.
Return on Equity (ROE)0.15
Return on Assets (ROA)0.08
Return on Invested Capital (ROIC)10.35%
Return on Capital Employed (ROCE)0.14
Revenue Per Employee3.31M
Profits Per Employee475.51K
Employee Count637
Asset Turnover0.81
Inventory Turnover6.58
Valuation Ratios
The current PE Ratio of MedCap AB is 34.2. MedCap AB’s PEG ratio is 7.70.
PE Ratio34.2
PS Ratio3.90
PB Ratio5.67
Price to Fair Value5.67
Price to FCF29.33
Price to Operating Cash Flow21.18
PEG Ratio7.70
Income Statement
In the last 12 months, MedCap AB had revenue of 2.11B and earned 219.80M in profits. Earnings per share was 14.67.
Revenue2.11B
Gross Profit321.00M
Operating Income300.20M
Pretax Income289.00M
Net Income219.80M
EBITDA473.90M
Earnings Per Share (EPS)14.67
Cash Flow
In the last 12 months, operating cash flow was 387.70M and capital expenditures -46.60M, giving a free cash flow of 341.10M billion.
Operating Cash Flow387.70M
Free Cash Flow341.10M
Free Cash Flow per Share22.62
Dividends & Yields
MedCap AB pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.35
52-Week Price Change-14.55%
50-Day Moving Average47.04
200-Day Moving Average47.45
Relative Strength Index (RSI)61.47
Average Volume (3m)4.00
Important Dates
MedCap AB upcoming earnings date is Oct 23, 2026, TBA (Confirmed).
Last Earnings DateJul 21, 2026
Next Earnings DateOct 23, 2026
Ex-Dividend Date―
Financial Position
MedCap AB as a current ratio of 2.01, with Debt / Equity ratio of 28.85%
Current Ratio2.01
Quick Ratio1.46
Debt to Market Cap0.03
Net Debt to EBITDA0.24
Interest Coverage Ratio9.53
Taxes
In the past 12 months, MedCap AB has paid 68.30M in taxes.
Income Tax68.30M
Effective Tax Rate0.24
Enterprise Valuation
MedCap AB EV to EBITDA ratio is 17.60, with an EV/FCF ratio of 29.73.
EV to Sales3.96
EV to EBITDA17.60
EV to Free Cash Flow29.73
EV to Operating Cash Flow24.33
Balance Sheet
MedCap AB has €286.30M in cash and marketable securities with €457.60M in debt, giving a net cash position of -€171.30M billion.
Cash & Marketable Securities€286.30M
Total Debt€457.60M
Net Cash-€171.30M
Net Cash Per Share-€11.36
Tangible Book Value Per Share€15.34
Margins
Gross margin is 38.31%, with operating margin of 14.24%, and net profit margin of 10.43%.
Gross Margin38.31%
Operating Margin14.24%
Pretax Margin13.71%
Net Profit Margin10.43%
EBITDA Margin22.48%
EBIT Margin15.20%
Analyst Forecast
The average price target for MedCap AB is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast22.45%
EPS Growth Forecast24.61%